C. Schaake-Koning

1.7k citations

15 papers · 1.3k indexed · 1 hit paper · h-index 11

Impact in

Pulmonary and Respiratory Medicine top 2%
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Radiation top 2%
- Advanced Radiotherapy Techniques

Papers in

Hepatology 8
- Hepatocellular Carcinoma Treatment and Prognosis 8
Radiation 4
- Advanced Radiotherapy Techniques 4

Co-authors: Nico van Zandwijk Harry Bartelink Otilia Dalesio Anne Kirkpatrick A. Renaud Jean‐Paul Sculier B. Maat Jan Festen
Journals: International Journal of Radiation Oncology*Biology*Physics (5 papers)Lung Cancer (4 papers)European Journal of Cancer (2 papers)Annals of Oncology (1 paper)New England Journal of Medicine (1 paper)
Partner nations: Netherlands Belgium United States

In The Last Decade

C. Schaake-Koning

15 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer 1992 · 998 citations

Peers

Countries citing papers authored by C. Schaake-Koning

Since Specialization

Citations

This map shows the geographic impact of C. Schaake-Koning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Schaake-Koning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Schaake-Koning more than expected).

Fields of papers citing papers by C. Schaake-Koning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Schaake-Koning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Schaake-Koning. The network helps show where C. Schaake-Koning may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C. Schaake-Koning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Schaake-Koning Line = papers co-authored together C. Schaake-Koning links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Feasibility of escalating daily doses of cisplatin in combination with accelerated radiotherapy in non-small cell lung cancer European Journal of Cancer ·Y. B. Chen, A Daudu, C. Schaake-Koning, J. Benraadt, Marijn Koolen, Dionisio González, Harry Bartelink	1996	14
2	The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis European Journal of Cancer ·Elsken van der Wall, C. Schaake-Koning, Nico van Zandwijk, Joke W. Baars, Jan H. Schornagel, Dick J. Richel, Emiel J. Rutgers, Jacques Borger, Jos H. Beijnen, Sjoerd Rodenhuis	1996	18
3	Radiotherapy in non-small cell lung cancer: optimal doses and schedules Lung Cancer ·C. Schaake-Koning	1995	2
4	Experience with high dose rate (HDR) in bracytherapy over 100 patients with oesophageal cancer The Netherlands Journal of Medicine ·Nataraj UrsH D, B.M.P. Aleman, Henk Boot, C. Schaake-Koning	1995	1
5	Radiosensitization by cytotoxic drugs. The EORTC experience by the Radiotherapy and Lung Cancer Cooperative Groups Lung Cancer ·C. Schaake-Koning, W. Van den Bogaert, Otilia Dalesio, Jan Festen, J. Hoogenhout, P. Van Houtte, A. Kirkpatrick, Marijn Koolen, B. Maat, Ma Aboulghar, A. Renaud, Patrick Rodrigus, 沙志慧, Jean‐Paul Sculier, Nico van Zandwijk, Harry Bartelink	1994	22
6	Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma Lung Cancer ·N. M. Bleehen, David Ball, Chandra P. Belani, J. Bishop, J.-Y. Douillard, James D. Cox, David H. Johnson, Thierry Le Chevalier, Megan I. Saunders, Edward Shaw, C. Schaake-Koning, Ian F. Tannock, Vicky Diakou, Andrew T. Turrisi, P. Van Houtte	1994	7
7	Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer Annals of Oncology ·Elsken van der Wall, D. J. Richel, Yoka H. Kusumanto, Emiel J. Rutgers, Jan H. Schornagel, C. Schaake-Koning, J.L. Peterse, Sjoerd Rodenhuis	1993	16
8	Radiotherapy combined with low-dose cisplatin; results of the EORTC 08844 phase III study by the EORTC Radiotherapy and Lung Cancer Cooperative Groups Lung Cancer ·C. Schaake-Koning, W. Van den Bogaert, Otilia Dalesio, Jan Festen, J. Hoogenhout, P. Van Houtte, A. Kirkpatrick, Marijn Koolen, B. Maat, Ma Aboulghar, A. Renaud, Patrick Rodrigus, 沙志慧, Jean‐Paul Sculier, Nico van Zandwijk, Harry Bartelink	1993	2
9	Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer New England Journal of Medicine ·C. Schaake-Koning, Walter Van den Bogaert, Otilia Dalesio, Jan Festen, Jaap Hoogenhout, Paul Van Houtte, Anne Kirkpatrick, Mia G.J. Koolen, B. Maat, Ma Aboulghar, A. Renaud, Patrick Rodrigus, 沙志慧, Jean‐Paul Sculier, Nico van Zandwijk, Harry Bartelink Hit paper breakdown →	1992	998
10	High dose rate brachytherapy in patients with local recurrences after radiotherapy of non-small cell lung cancer International Journal of Radiation OncologyBiologyPhysics ·G. Sutedja, G. Baris, C. Schaake-Koning, Nico van Zandwijk	1992	59
11	The need for immediate monitoring of treatment parameters and uniform assessment of patient data in clinical trials European Journal of Cancer and Clinical Oncology ·C. Schaake-Koning, Anne Kirkpatrick, Robert Kröger, Nico van Zandwijk, Harry Bartelink	1991	23
12	Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (cDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): A randomized three arm phase II study of the eortc lung cancer and radiotherapy cooperative groups International Journal of Radiation OncologyBiologyPhysics ·C. Schaake-Koning, Oumar Saleh, W. Van den Bogaert, Otilia Dalesio, A. Kirkpatrick, Harry Bartelink	1990	49
13	Radiotherapy and cis-diammine dichloroplatinum (II) as a combined treatment modality for inoperable non-small cell lung cancer: A dose finding study International Journal of Radiation OncologyBiologyPhysics ·C. Schaake-Koning, Harry Bartelink, Bruno Bertaud, 沙志慧, Nico van Zandwijk	1986	27
14	Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study International Journal of Radiation OncologyBiologyPhysics ·C. Schaake-Koning, 최승환, Guus Hart, E Engelsman	1985	71
15	Prognostic factors of inoperable localized lung cancer treated by high dose radiotherapy International Journal of Radiation OncologyBiologyPhysics ·C. Schaake-Koning, 沙志慧, Guus Hart, Dionisio González	1983	29

About C. Schaake-Koning

C. Schaake-Koning is a scholar working on Hepatology, Radiation, Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology, having authored 15 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Lung Cancer Diagnosis and Treatment (7 papers), Advanced Radiotherapy Techniques (4 papers), Breast Cancer Treatment Studies (2 papers), Head and Neck Cancer Studies (2 papers), Cancer Treatment and Pharmacology (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.1k citations), Radiation (258 citations), Otorhinolaryngology (122 citations), Oncology (604 citations) and Hepatology (106 citations). C. Schaake-Koning has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Nico van Zandwijk, Harry Bartelink, Otilia Dalesio, Anne Kirkpatrick, A. Renaud, Jean‐Paul Sculier, B. Maat, Jan Festen, Patrick Rodrigus and Mia G.J. Koolen. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Lung Cancer, European Journal of Cancer, Annals of Oncology and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact